MarketCap
Facebook
X
TelegramAnnual report 2021
added 12-23-2023
Burning Rock Biotech Limited Total Current Liabilities 2011-2026 | BNR
Annual Total Current Liabilities Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 372 M | 242 M | 164 M | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 372 M | 164 M | 259 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
1.71 B | $ 120.47 | 1.2 % | $ 36.6 B |  USA |
 |
Anixa Biosciences
ANIX
|
1.97 M | $ 2.9 | 2.47 % | $ 94.1 K | USA |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Celcuity
CELC
|
31.7 M | $ 108.86 | 1.36 % | $ 4.29 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 27.97 | 1.43 % | $ 777 M | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 14.17 | 2.72 % | $ 428 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 179.12 | 1.95 % | $ 8.88 B | USA |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
IDEXX Laboratories
IDXX
|
1.15 B | $ 638.42 | 0.62 % | $ 51.3 B | USA |
 |
Illumina
ILMN
|
1.55 B | $ 131.73 | 1.67 % | $ 20.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 282.44 | -0.19 % | $ 23.5 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 79.34 | 0.63 % | $ 5.35 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
14.3 M | $ 15.04 | -2.97 % | $ 1.95 B | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 319.33 | 0.2 % | $ 27.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
134 M | $ 5.43 | 2.65 % | $ 503 M | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 9.65 | 1.1 % | $ 1.24 B | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.12 | - | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 209.29 | 0.44 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
6.81 B | $ 204.98 | 0.48 % | $ 146 B | USA |
 |
National Research Corporation
NRC
|
36.2 M | $ 13.39 | - | $ 329 M | USA |
 |
Organovo Holdings
ONVO
|
3.74 M | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | $ 103.46 | 0.09 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
175 M | $ 8.57 | -1.95 % | $ 537 M | USA |
 |
OPKO Health
OPK
|
193 M | $ 1.21 | 1.68 % | $ 840 M | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 10.5 | 1.94 % | $ 298 M | Israel |
 |
DexCom
DXCM
|
2.14 B | $ 71.55 | -2.09 % | $ 27.9 B | USA |
 |
PerkinElmer
PKI
|
1.33 B | - | -0.91 % | $ 14.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
72.8 M | $ 1.62 | 6.25 % | $ 486 M | USA |
 |
Psychemedics Corporation
PMD
|
4.71 M | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 111.03 | 2.14 % | $ 9.16 B |  Irlanda |
 |
Quotient Limited
QTNT
|
59.5 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
3.14 M | $ 25.4 | 1.7 % | $ 33 M | USA |
 |
Renalytix AI plc
RNLX
|
11.5 M | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 19.2 | 2.13 % | $ 1.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |